Publications & Works

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings

Noyan H., ERDAĞ E., TÜZÜN E., YAYLIM İ., KÜÇÜKHÜSEYİN Ö., HAKAN M. T., et al.
Schizophrenia Research, vol.229, pp.27-37, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier

Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum

Pries L. -., Dal Ferro G. A., van Os J., Delespaul P., Kenis G., Lin B. D., et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, vol.29, 2020 (SCI-Expanded) identifier identifier identifier

Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia A Real-World Multicenter, Retrospective, Mirror-Image Study

Devrimci-Ozguven H., ATMACA M., Baran Z., Cengisiz C., Cinar C., Erol A., et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, vol.39, no.6, pp.604-610, 2019 (SCI-Expanded) identifier identifier identifier

White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

Schepers E., Lousberg R., Guloksuz S., Pries L., Delespaul P., Kenis G., et al.
FRONTIERS IN PSYCHIATRY, vol.10, 2019 (SCI-Expanded) identifier identifier identifier

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

Pries L., Lage-Castellanos A., Delespaul P., Kenis G., Luykx J. J., Lin B. D., et al.
SCHIZOPHRENIA BULLETIN, vol.45, no.5, pp.960-965, 2019 (SCI-Expanded) identifier identifier identifier

A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale

Mucci A., Vignapiano A., Bitter I., Austin S. F., Delouche C., Dollfus S., et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol.29, no.8, pp.947-959, 2019 (SCI-Expanded) identifier identifier identifier

Lower prepulse inhibition in clinical high-risk groups but not in familial risk groups for psychosis compared with healthy controls

Togay B., Cikrikcili U., Bayraktaroglu Z., Uslu A., Noyan H., Ucok A.
EARLY INTERVENTION IN PSYCHIATRY, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

Guloksuz S., Pries L., Delespaul P., Kenis G., Luykx J. J., Lin B. D., et al.
WORLD PSYCHIATRY, vol.18, no.2, pp.173-182, 2019 (SCI-Expanded) identifier identifier identifier

Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia

Ucok A., Yagcioglu E. A., YILDIZ M., Kaymak S. U., SAKA M. C., Tasdelen R., et al.
PSYCHIATRY RESEARCH, vol.275, pp.149-154, 2019 (SCI-Expanded) identifier identifier identifier

Psychometric liability to psychosis and childhood adversities are associated with shorter telomere length: A study on schizophrenia patients, unaffected siblings, and non-clinical controls

Cevik B., MANÇE ÇALIŞIR Ö., Atbasoglu E. C., SAKA M. C., ALPTEKİN K., ÜÇOK V. A., et al.
JOURNAL OF PSYCHIATRIC RESEARCH, vol.111, pp.169-185, 2019 (SCI-Expanded) Sustainable Development identifier

Responding to experienced and anticipated discrimination (READ): anti -stigma training for medical students towards patients with mental illness - study protocol for an international multisite non-randomised controlled study

Deb T., Lempp H., Bakolis I., Vince T., Waugh W., Henderson C., et al.
BMC MEDICAL EDUCATION, vol.19, 2019 (SCI-Expanded) Sustainable Development identifier identifier identifier

The impact of a six-month interpersonal group psychotherapy on functionality of patients with schizophrenia in a community mental health center

Sukru F., Ozturk M., Kilic O., Ister Guneytepe S., Ucok A.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, vol.19, no.6, pp.559-566, 2018 (SCI-Expanded) Sustainable Development identifier identifier

Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

ATBAŞOĞLU E. C., Gumus-Akay G., Guloksuz S., SAKA M. C., Ucok A., ALPTEKİN K., et al.
PSYCHOPHARMACOLOGY, vol.235, no.4, pp.1029-1039, 2018 (SCI-Expanded) identifier identifier identifier

Relationship of obsessive-compulsive symptoms to clinical variables and cognitive functions in individuals at ultra high risk for psychosis

Soyata A. Z., Akisik S., Inhanli D., Noyan H., Ucok A.
PSYCHIATRY RESEARCH, vol.261, pp.332-337, 2018 (SCI-Expanded) identifier identifier identifier

Electrophysiological and Neuroimaging Research on Negative Symptoms: Future Challenges

Mucci A., Ucok A., Nielsen M. O.
CLINICAL EEG AND NEUROSCIENCE, vol.49, no.1, pp.3-5, 2018 (SCI-Expanded) identifier identifier identifier

Relationship Between Persistent Negative Symptoms and Findings of Neurocognition and Neuroimaging in Schizophrenia

Ince E., Ucok A.
CLINICAL EEG AND NEUROSCIENCE, vol.49, no.1, pp.27-35, 2018 (SCI-Expanded) identifier identifier identifier

Deficits in Go and NoGo P3 potentials in patients with schizophrenia.

ERTEKIN E., Üçok A., KESKIN-ERGEN Y., DEVRIM-ÜÇOK M.
Psychiatry research, vol.254, pp.126-132, 2017 (SCI-Expanded) identifier identifier identifier

Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases

Mucci A., MERLOTTI E., Ucok A., ALEMAN A., Galderisi S.
SCHIZOPHRENIA RESEARCH, vol.186, pp.19-28, 2017 (SCI-Expanded) Sustainable Development identifier identifier identifier

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

Howes O. D., McCutcheon R., Agid O., de Bartolomeis A., van Beveren N. J. M., Birnbaum M. L., et al.
AMERICAN JOURNAL OF PSYCHIATRY, vol.174, no.3, pp.216-229, 2017 (SCI-Expanded) identifier identifier identifier

The Relationship of Negative Symptom Severity with Cognitive Symptoms and Functioning in Subjects at Ultra High Risk for Psychosis

Ucok A., Cikrikcili U., Noyan H., Tabak O., Yokusoglu C., Samanli H. K., et al.
EARLY INTERVENTION IN PSYCHIATRY, vol.10, pp.88, 2016 (SCI-Expanded) identifier

Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study

Ucok A., Cikrikcili U., Ergul C., Tabak O., Salaj A., Karabulut S., et al.
CNS DRUGS, vol.30, no.10, pp.997-1006, 2016 (SCI-Expanded) identifier identifier identifier

Lack of progressive reduction in P3 amplitude after the first-episode of schizophrenia: A 6-year follow-up study

Devrim-Ucok M., Keskin-Ergen Y., Ucok A.
PSYCHIATRY RESEARCH, vol.243, pp.303-311, 2016 (SCI-Expanded) identifier identifier identifier

Validation of Turkish version of brief negative symptom scale

Polat Nazli I., Ergul C., Aydemir O., Chandhoke S., Ucok A., Gönül A. S.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, vol.20, no.4, pp.265-271, 2016 (SCI-Expanded) identifier identifier identifier

Discrimination in the workplace, reported by people with major depressive disorder: a cross-sectional study in 35 countries

Brouwers E. P. M., Mathijssen J., Van Bortel T., Knifton L., Wahlbeck K., Van Audenhove C., et al.
BMJ OPEN, vol.6, no.2, 2016 (SCI-Expanded) Sustainable Development identifier identifier identifier

Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

Schreiner A., Aadamsoo K., Altamura A. C., Franco M., Gorwood P., Neznanov N. G., et al.
SCHIZOPHRENIA RESEARCH, vol.169, pp.393-399, 2015 (SCI-Expanded) identifier identifier identifier

Clinical variables associated with suicide attempts in schizophrenia before and after the first episode

Togay B., Noyan H., Tasdelen R., Ucok A.
PSYCHIATRY RESEARCH, vol.229, pp.252-256, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia

Ucok A., Cikrikcili U., Karabulut S., Salaj A., Ozturk M., Tabak O., et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, vol.30, no.5, pp.290-295, 2015 (SCI-Expanded) identifier identifier identifier

Effects of paliperidone extended release on functioning level and symptoms of patients with recent onset schizophrenia: An open-label, single-arm, flexible-dose, 12-months follow-up study

Ucok A., Saka M. C., BILICI M.
NORDIC JOURNAL OF PSYCHIATRY, vol.69, no.6, pp.1708-1714, 2015 (SCI-Expanded) identifier identifier identifier

Negative symptom subgroups have different effects on the clinical course of schizophrenia after the first episode: A 24-month follow up study

Ergul C., Ucok A.
EUROPEAN PSYCHIATRY, vol.30, no.1, 2015 (SCI-Expanded) identifier identifier identifier

Obsessive compulsive symptoms are related to lower quality of life in patients with Schizophrenia

Ucok A., Tihan A. K., Karadayi G., Tukel R.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, vol.18, no.4, pp.243-247, 2014 (SCI-Expanded) identifier identifier identifier

Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study

Ucok A., Ergul C.
SCHIZOPHRENIA RESEARCH, vol.158, pp.241-246, 2014 (SCI-Expanded) identifier identifier identifier

Treatment Guidelines for Patients with Schizophrenia or Psychotic Disorder who are Hospitalized in a Psychiatry Clinic

ALPTEKİN K., Ucok A., Ayer A., Unal A., Erol A., Ensari H., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.24, no.3, pp.276-288, 2014 (SCI-Expanded) identifier identifier identifier

Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations

van Os J., Rutten B. P., Myin-Germeys I., Delespaul P., Viechtbauer W., van Zelst C., et al.
SCHIZOPHRENIA BULLETIN, vol.40, no.4, pp.729-736, 2014 (SCI-Expanded) identifier identifier identifier

The role of metformin and topiramate in reducing the side effects due to antipsychotics in patients with schizophrenia

Karabulut S., Ergul C., Ozturk M., Ucok A.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, vol.15, no.2, pp.174-180, 2014 (SCI-Expanded) Sustainable Development identifier identifier

Factor structure of the Subjective Well-being under Neuroleptic treatment Scale-short form in schizophrenic outpatients: Five factors or only one?

Pazvantoglu O., Simsek O. F., Aydemir O., Sarisoy G., Boke O., Ucok A.
NORDIC JOURNAL OF PSYCHIATRY, vol.68, no.4, pp.259-265, 2014 (SCI-Expanded) identifier identifier identifier

PERSISTANT NEGATIVE SYMPTOMS AFTER FIRST-EPISODE SCHIZOPHRENIA; RESULTS OF 2 YEARS FOLLOW-UP

Ucok A., Ergul C.
SCHIZOPHRENIA RESEARCH, vol.153, 2014 (SCI-Expanded) identifier

NEGATIVE SYMPTOM SUBGROUPS HAVE DIFFERENT EFFECTS ON CLINICAL COURSE AFTER FIRST EPISODE OF SCHIZOPHRENIA: A 24 MONTHS FOLLOW-UP STUDY

Ergul C., Ucok A.
SCHIZOPHRENIA RESEARCH, vol.153, 2014 (SCI-Expanded) identifier

A RANDOMIZED, ACTIVE-CONTROLLED RATER-BLINDED 2-YEAR STUDY OF PALIPERIDONE PALMITATE VERSUS INVESTIGATORS' CHOICE OF ORAL ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA (PROSIPAL)

Schreiner A., Aadamsoo K., Altamura C., Franco M., Gorwood P., Neznanov N. G., et al.
SCHIZOPHRENIA RESEARCH, vol.153, 2014 (SCI-Expanded) identifier

P3 ABNORMALITIES IN NEUROLEPTIC-NAIVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS AND IN THEIR HEALTHY SIBLINGS

Devrim-Ucok M., Ucok A.
SCHIZOPHRENIA RESEARCH, vol.153, 2014 (SCI-Expanded) identifier

NEGATIVE SYMPTOM SUBGROUPS HAVE DIFFERENT EFFECTS ON CLINICAL COURSE AFTER FIRST EPISODE OF SCHIZOPHRENIA: A 24-MONTH FOLLOW-UP STUDY

Ergul C., Ucok A.
SCHIZOPHRENIA RESEARCH, vol.153, 2014 (SCI-Expanded) identifier

A RANDOMIZED, ACTIVE-CONTROLLED RATER-BLINDED 2-YEAR STUDY OF PALIPERIDONE PALMITATE VERSUS INVESTIGATORS' CHOICE OF ORAL ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA (PROSIPAL)

Schreiner A., Aadamsoo K., Altamura A. C., Franco M., Goorwood P., Neznanov N. G., et al.
EUROPEAN PSYCHIATRY, vol.29, 2014 (SCI-Expanded) identifier

Cognitive deficits in clinical and familial high risk groups for psychosis are common as in first episode schizophrenia

Ucok A., Direk N., KOYUNCU A., Keskin-Ergen Y., Yuksel C., GULER J., et al.
SCHIZOPHRENIA RESEARCH, vol.151, pp.265-269, 2013 (SCI-Expanded) identifier identifier identifier

The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia

Sahin S., Yuksel C., GULER J., Karadayi G., Akturan E., Gode E., et al.
EARLY INTERVENTION IN PSYCHIATRY, vol.7, no.4, pp.414-420, 2013 (SCI-Expanded) identifier identifier identifier

Anticipated discrimination is related to symptom severity, functionality and quality of life in schizophrenia

Ucok A., Karadayi G., Emiroglu B., sartorius N.
PSYCHIATRY RESEARCH, vol.209, no.3, pp.333-339, 2013 (SCI-Expanded) identifier identifier identifier

Reliability and Validity of Subjective Well-Being Under Neuroleptics Scale-Short Form-Turkish Version

Pazvantoglu O., Simsek O. F., AYDEMİR Ö., SARISOY G., Korkmaz I. Z., Mor S., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.22, no.3, pp.235-243, 2012 (SCI-Expanded) identifier identifier

No gender differences in social outcome in patients suffering from schizophrenia

Galderisi s., bucci p., Ucok A., Peuskens J.
EUROPEAN PSYCHIATRY, vol.27, no.6, pp.406-408, 2012 (SCI-Expanded) identifier identifier identifier

Employment and its relationship with functionality and quality of life in patients with schizophrenia: EGOFORS Study

Ucok A., Gorwood P., Karadayi G.
EUROPEAN PSYCHIATRY, vol.27, no.6, pp.422-425, 2012 (SCI-Expanded) identifier identifier identifier

Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia A Prospective, Randomized, Controlled Trial

Schreiner A., Niehaus D., Shuriquie N. A., Aadamsoo K., Korcsog P., Salinas R., et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, vol.32, no.4, pp.449-457, 2012 (SCI-Expanded) identifier identifier identifier

OBSESSIVE COMPULSIVE SYMPTOMS BUT NOT OBSESSIVE-COMPULSIVE DISORDER ARE RELATED TO LOWER QUALITY OF LIFE IN SCHIZOPHRENIA

ÜÇOK V. A., Tihan A., Tukel R.
SCHIZOPHRENIA RESEARCH, vol.136, 2012 (SCI-Expanded) identifier

Self-stigmatization among patients with schizophrenia, their relatives and patients with major depressive disorder

YILDIZ M., Ozten E., Isik S., Ozyildirim I., Karayun D., Cerit C., et al.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, vol.13, no.1, pp.1-7, 2012 (SCI-Expanded) identifier identifier

Bir Üniversite Hastanesi Psikiyatri Servisinde Yatarak Tedavi Edilen Ergen Hastaların Klinik ve Sosyodemografik Özellikleri.

COŞKUN M., Karakoç S., Ayaydın H., Bozkurt H., SÜLEYMAN F., ZOROĞLU S. S., et al.
Çocuk ve Gençlik Ruh Sağlığı Dergisi, vol.19, pp.17-24, 2012 (SCI-Expanded)

Anticipated discrimination among people with schizophrenia

Ucok A., Brohan E., Rose D., Sartorius N., Leese M., Yoon C. K., et al.
ACTA PSYCHIATRICA SCANDINAVICA, vol.125, no.1, pp.77-83, 2012 (SCI-Expanded) Sustainable Development identifier identifier identifier

Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia

Karadayi G., Emiroglu B., Ucok A.
COMPREHENSIVE PSYCHIATRY, vol.52, no.6, pp.701-707, 2011 (SCI-Expanded) identifier identifier identifier

Remission after first-episode schizophrenia: Results of a long-term follow-up

Ucok A., Serbest S., Kandemir P. E.
PSYCHIATRY RESEARCH, vol.189, no.1, pp.33-37, 2011 (SCI-Expanded) identifier identifier identifier

Obsessive compulsive disorder and symptoms may have different effects on schizophrenia

Ucok A., CEYLAN M. E., Tihan A. K., LAPCIN S., GER C., Tukel R.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol.35, no.2, pp.429-433, 2011 (SCI-Expanded) identifier identifier identifier

An Unusual Late Presentation of Subacute Sclerosing Panencephalitis With Psychotic Symptoms

Baran Z., Hanagasi H. A., Ucok A.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, vol.22, no.1, 2010 (SCI-Expanded) identifier identifier identifier

COMT Val158Met polymorphism is related with interpersonal problem solving in schizophrenia

Ucok A., Öztürk M. S., Duman Z., Saruhan-Direskeneli G.
European Psychiatry, vol.25, no.6, pp.320-322, 2010 (SCI-Expanded) identifier identifier identifier

THE EFFECTIVENESS OF A PSYCHOEDUCATIONAL GROUP PROGRAM WITH INPATIENTS BEING TREATED FOR CHRONIC MENTAL ILLNESS

DUMAN Z. Ç., Yildirim N. K., Ucok A., Er F., Kanik T.
SOCIAL BEHAVIOR AND PERSONALITY, vol.38, no.5, pp.657-666, 2010 (SSCI) Sustainable Development identifier identifier

Validation of the Turkish Version of the "Functional Remission of General Schizophrenia" (FROGS) Scale

Emiroglu B., Karadayi G., AYDEMİR Ö., Ucok A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.46, pp.15-24, 2009 (SCI-Expanded) identifier

Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study

ALPTEKİN K., Hafez J., Brook S., AKKAYA C., Tzebelikos E., Ucok A., et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, vol.24, no.5, pp.229-238, 2009 (SCI-Expanded) identifier identifier identifier

THE VALIDATION OF TURKISH VERSION OF PERSONAL AND SOCIAL PERFORMANCE SCALE (PSP)

Aydemir O., Ucok A., Danaci A. E., Sarioz F., Canpolat T., Karadayi G., et al.
VALUE IN HEALTH, vol.12, no.3, 2009 (SCI-Expanded) identifier

Analysis of Social Class by LCA in Patients with Schizophrenia: Change in Psychopathology after 12 Month of Treatment

Saylan M., Ucok A., Uguz S., Treuer T., Sir A.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.19, no.1, pp.29-38, 2009 (SCI-Expanded) identifier

Altered Metabolic Integrity of Corpus Callosum Among Individuals at Ultra High Risk of Schizophrenia and First-Episode Patients

Aydin K., Ucok A., GULER J.
BIOLOGICAL PSYCHIATRY, vol.64, no.9, pp.750-757, 2008 (SCI-Expanded) identifier identifier identifier

Do psychiatrists examine sexual dysfunction in schizophrenia patients?

Ucok A., Incesu C., Aker T., Erkoc S.
JOURNAL OF SEXUAL MEDICINE, vol.5, no.8, pp.2000-2001, 2008 (SCI-Expanded) identifier identifier identifier

Side effects of atypical antipsychotics: a brief overview

Ucok A., gaebel W.
WORLD PSYCHIATRY, vol.7, no.1, pp.58-62, 2008 (SCI-Expanded) Sustainable Development identifier identifier

Effectiveness of a structured diet program in antipsychotic-induced weight gain in patients with schizophrenia

Direk N., Ucok A.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, vol.12, no.3, pp.238-240, 2008 (SCI-Expanded) identifier identifier identifier

The effects of childhood trauma in patients with first-episode schizophrenia

Ucok A., Bikmaz S.
ACTA PSYCHIATRICA SCANDINAVICA, vol.116, no.5, pp.371-377, 2007 (SCI-Expanded) identifier identifier identifier

Quantitative proton MR spectroscopy findings in the corpus callosum of patients with schizophrenia suggest callosal disconnection

Aydin K., Ucok A., Cakir S.
AMERICAN JOURNAL OF NEURORADIOLOGY, vol.28, no.10, pp.1968-1974, 2007 (SCI-Expanded) identifier identifier identifier

Novelty P3 and P3b in first-episode schizophrenia and chronic schizophrenia

DEVRIM-UCOK M., KESKIN-ERGEN H. Y., Ucok A.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol.30, no.8, pp.1426-1434, 2006 (SCI-Expanded) identifier identifier identifier

Family centered evaluation of treatment outcome in schizophrenia: Marmara family interview for the Assesment of Psychiatric Treatment

Kuscu M. K., Duman Z. C., Akman M., Ucok A., Goktepe E. O.
TURK PSIKIYATRI DERGISI, vol.17, no.3, pp.192-203, 2006 (SSCI) identifier identifier identifier

Mismatch negativity at acute and post-acute phases of first-episode schizophrenia

Derim-Ucok M., Keskin-Ergen H. Y., Ucok A.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, vol.61, no.3, pp.345, 2006 (SCI-Expanded) identifier

Cognitive predictors of skill acquisition on social problem solving in patients with schizophrenia

Ucok A., Cakir S., Duman Z. C., Discigal A., Kandemir P., Atli H.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, vol.256, no.6, pp.388-394, 2006 (SCI-Expanded) identifier identifier identifier

P300 responses in recent-onset schizophrenia patients elicited during N-back task

Keskin-Ergen H. Y., Ertekin E., Ucok A., Devrim-Ucok M.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, vol.61, no.3, pp.345, 2006 (SCI-Expanded) identifier

Effects of an antistigma program on medical students' attitudes towards people with schizophrenia

Altindag A., Yanik M., Ucok A., Alptekin K., Ozkan M.
PSYCHIATRY AND CLINICAL NEUROSCIENCES, vol.60, no.3, pp.283-288, 2006 (SCI-Expanded) Sustainable Development identifier identifier identifier

Electroconvulsive therapy in first-episode schizophrenia

Ucok A., Cakar S.
JOURNAL OF ECT, vol.22, no.1, pp.38-42, 2006 (SCI-Expanded) identifier identifier identifier

One year outcome in first episode schizophrenia - Predictors of relapse

Ucok A., Polat A., Cakir S., Genc A.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, vol.256, no.1, pp.37-43, 2006 (SCI-Expanded) identifier identifier identifier

Frequency of obsessive compulsive symptoms and disorder in patients with schizophrenia : importence for prognosis

Ucok A., Tukel R., Ozgen G., Saylan M., Uzuner G.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, vol.32, no.1, pp.41-44, 2006 (SCI-Expanded) Sustainable Development identifier identifier identifier

Histories of childhood maltreatment in first-episode schizophrenia

Ucok A., Bykmaz S.
ACTA PSYCHIATRICA SCANDINAVICA, vol.114, pp.59, 2006 (SCI-Expanded) identifier

Disability in schizophrenia: Clinical correlates and prediction over 1-year follow-up

Alptekin K., Erkoc S., Gogus A., Kultur S., Mete L., Ucok A., et al.
PSYCHIATRY RESEARCH, vol.135, no.2, pp.103-111, 2005 (SCI-Expanded) Sustainable Development identifier identifier identifier

Human leukocyte antigen alleles in patients with bipolardisorder in Turkey

Ucok A., Akar U., Polat A.
EUROPEAN PSYCHIATRY, vol.20, no.1, pp.83, 2005 (SCI-Expanded) identifier identifier identifier

Cigarette smoking among patients with schizophrenia and bipolar disorders

Ucok A., Polat A., Bozkurt O., Meteris H.
PSYCHIATRY AND CLINICAL NEUROSCIENCES, vol.58, no.4, pp.434-437, 2004 (SCI-Expanded) identifier identifier identifier

Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia

Ucok A., Polat A., Genc A., Cakir S., Turan N.
JOURNAL OF PSYCHIATRIC RESEARCH, vol.38, no.2, pp.163-168, 2004 (SCI-Expanded) identifier identifier identifier

Bipolar disorder treatment guidelines of Psychiatric Association of Turkey: Main differences as reflections of countrywide applications and their rationale

Vahip S., Yazici O., Akdeniz F., Gonul A., Karadag F., Kocadere M., et al.
JOURNAL OF AFFECTIVE DISORDERS, vol.78, 2004 (SCI-Expanded) identifier

Attitudes of psychiatrists toward patients with schizophrenia

Ucok A., Polat A., Sartorius N., Erkoc S., Atakli C.
PSYCHIATRY AND CLINICAL NEUROSCIENCES, vol.58, no.1, pp.89-91, 2004 (SCI-Expanded) identifier identifier identifier

Treatment guidelines for bipolar disorders of Psychiatric Association of Turkey

Vahip S., Yazici O., Akdeniz F., Gonul A., Karadag F., Kocadere M., et al.
ACTA PSYCHIATRICA SCANDINAVICA, vol.110, pp.40, 2004 (SCI-Expanded) identifier

Quetiapine treatment in a patients with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania

Matur Z., Ucok A.
ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, vol.40, no.2, pp.150-152, 2003 (SSCI) identifier identifier identifier

Unipolar mania: a distinct disorder?

Yazici O., Kora K., Ucok A., Saylan M., Ozdemir O., Kiziltan E., et al.
JOURNAL OF AFFECTIVE DISORDERS, vol.71, pp.97-103, 2002 (SCI-Expanded) identifier identifier identifier

A multi-center 1-year follow-up study of patients with schizophrenia in Turkey: Relapse and its predictors

Ucok A., Kultur S., Alptekin K., Erkoc S., Gogus A., Mete L., et al.
SCHIZOPHRENIA RESEARCH, vol.53, no.3, pp.251, 2002 (SCI-Expanded) identifier

Relation of family history of schizophrenia with clinical variables in patients with schizophrenia

Ucok A., Kultur S., Alptekin K., Erkoc S., Gogus A., Mete L., et al.
SCHIZOPHRENIA RESEARCH, vol.53, no.3, pp.81, 2002 (SCI-Expanded) identifier

Predictors of relapse following response from a first episode of schizophrenia

Ucok A., Polat A., Saylan M., Turan N.
SCHIZOPHRENIA RESEARCH, vol.53, no.3, pp.54, 2002 (SCI-Expanded) identifier

Co-morbid substance abuse and smoking in Turkish patients with schizophrenia

ALPTEKİN K., Erkoc S., GÖĞÜŞ A. K., Kultur S., Mete L., ÜÇOK V. A., et al.
SCHIZOPHRENIA RESEARCH, vol.53, no.3, pp.224, 2002 (SCI-Expanded) identifier

Disability in schizophrenia: A multicenter study of 1-year follow-up of patients with schizophrenia in Turkey

ALPTEKİN K., Erkoc S., GÖĞÜŞ A. K., Kultur S., Mete L., ÜÇOK V. A., et al.
SCHIZOPHRENIA RESEARCH, vol.53, no.3, pp.261, 2002 (SCI-Expanded) identifier

Predictors of lithium prophylaxis in bipolar patients

Yazici O., Kora K., Ucok A., Tunali D., Turan N.
JOURNAL OF AFFECTIVE DISORDERS, vol.55, pp.133-142, 1999 (SCI-Expanded) identifier identifier identifier

Comorbidity of personality disorders with bipolar mood disorders

Ucok A., KARAVELI D., KUNDAKCI T., YAZICI O.
COMPREHENSIVE PSYCHIATRY, vol.39, no.2, pp.72-74, 1998 (SCI-Expanded) Sustainable Development identifier identifier identifier

Seclusion in closed psychiatric wards in Turkey

Ucok V. A., KORA K., BOSTANCI F., ER F.
EUROPEAN JOURNAL OF PSYCHIATRY, vol.10, no.3, pp.149-154, 1996 (SSCI) Sustainable Development identifier identifier

Maintenance ECT in a patient with catatonic schizophrenia and tardive dyskinesia

Ucok A., Ucok G.
CONVULSIVE THERAPY, vol.12, no.2, pp.108-112, 1996 (SCI-Expanded) identifier identifier identifier

NORADRENERGIC AND SEROTONINERGIC DEPRESSION

YAZICI O., ARICIOGLU F., GURVIT G., UCOK A., TASTABAN Y., CANBERK O., et al.
JOURNAL OF AFFECTIVE DISORDERS, vol.27, no.2, pp.123-129, 1993 (SCI-Expanded) identifier identifier identifier

Articles Published in Other Journals

Antistigma Efforts in Turkey The Turkish Program Against Stigmatization and Discrimination Because of Schizophrenia as a Part of the World Psychiatric Association Global Program

Soygur H., ÜÇOK V. A., Akbiyik D. I.
INTERNATIONAL JOURNAL OF MENTAL HEALTH, vol.36, no.3, pp.58-65, 2007 (ESCI) identifier identifier

The Efficacy of Psychoeducational Group Therapy in Inpatients

ÇETİNKAYA DUMAN Z., Kocaman N., ÜÇOK V. A., Er F., Kanik T., Doganer M.
DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, vol.19, no.2, pp.64-71, 2006 (ESCI) identifier

Refereed Congress / Symposium Publications in Proceedings

Doğan E. E., Mutlu Ü., Hacişahinoğulları H., Gürşahbaz O. C., Üçok V. A., Soyluk Selçukbiricik Ö., et al.
Endokurs 5, Antalya, Turkey, 10 - 14 November 2021, pp.148 Creative Commons License

Negatif Belirtiler Özdeğerlendirme Ölçeğinin Türkçe Geçerlik ve Güvenilirlik Çalışması

Polat I., İnce Guliyev E., Elmas S., Abdulhamid S., Aydemir Ö., Üçok V. A.
55. Ulusal Psikiyatri Kongresi, İstanbul, Turkey, 23 - 27 October 2019, vol.30, pp.44

RELATIONSHIP BETWEEN FORMAL THOUGHT DISORDER, AND FUNCTIONING IN INDIVIDUALS WITH ULTRA HIGH RISK FOR PSYCHOSIS

Ucok A., Senay O., Karakas B.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florida, United States Of America, 10 - 14 April 2019, vol.45 identifier

Neurocognition for the classification of first episode schizophrenia, unaffected family members and healthy controls: A machine learning study

Ince E., Kalmady S. V., Greiner R., Dursun S., Ucok A.
31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, Spain, 6 - 09 October 2018, vol.29 identifier

ŞİZOFRENİ HASTALARI VE KARDEŞLERİNDE KİNÜRENİN YOLAĞI METABOLİTLERİ, VİTAMİN D VE İNFLAMASYON BELİRTEÇLERİNİN KOGNİSYON VE KLİNİK BELİRTİLERLE İLİŞKİSİ

Noyan H., TÜZÜN E., Erdağ E., HAKAN M. T., KÜÇÜKHÜSEYİN Ö., YAYLIM İ., et al.
II. Türkiye in vitro Diyagnostik(IVD)Sempozyumu, İzmir, Turkey, 10 - 22 May 2017, pp.1

LOWER PREPULSE INHIBITION IN CLINICAL HIGH-RISK GROUP BUT NOT IN FAMILIAL RISK GROUP FOR PSYCHOSIS COMPARED TO HEALTHY CONTROLS

Ucok A., Togay B., Cikrikcili U., Bayraktaroglu Z.
16th International Congress on Schizophrenia Research (ICOSR), California, United States Of America, 24 - 28 March 2017, vol.43 identifier

Psikoz için yüksek risk grubundaki bireylerde dinlenim durumu fonksiyonel manyetik rezonans görüntüleme bulgularının sağlıklı kontroller ile karşılaştırılması

BÜLBÜL Ö., KURT E., Ulaşoğlu Yıldız C., Kıçik A., DEMİRALP T., Noyan H., et al.
52. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 16 - 20 November 2016, pp.11-12

Şizofrenili Hastalarda Negatif Belirtiler ile İlgili Değişkenler

Ergül C., Polat Nazli I., Aydemir Ö., Gönül A. S., Üçok V. A.
51. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 25 - 29 November 2015, pp.129

Şizofrenili Hastalarda Anhedoninin Alt Bileşenleri ile İlgili Değişkenler

Ergül C., Polat I., Aydemir Ö., Gönül A. S., Üçok V. A.
51. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 25 - 29 November 2015, pp.129

Kısa Negatif Belirti Ölçeğinin Türkçe Geçerlilik ve Güvenilirlik Çalışması

Polat I., Ergül C., Aydemir Ö., Üçok V. A., Gönül A. S.
51. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 25 - 29 November 2015, pp.77

HISTORY OF CHILDHOOD PHYSICAL TRAUMA HAS A NEGATIVE IMPACT ON COGNITIVE FUNCTIONING IN INDIVIDUALS AT ULTRA HIGH RISK FOR PSYCHOSIS

Ucok A.
15th International Congress on Schizophrenia Research (ICOSR), Colorado, United States Of America, 28 March - 01 April 2015, vol.41 identifier

evalualtion ofcognition in the first degree relatives of patients with schizophreia: Association between negative schizotypal personality traits and cognitive dysfunctions

Noyan H., ÜÇOK V. A.
1st Joint Turkish-German Symposium on human neuroscience, Berlin, Germany, 5 - 07 June 2014, vol.1, no.1, pp.30-31 Creative Commons License

GO AND NOGO P300 ARE NOT IMPAIRED IN SUBJECTS AT ULTRA HIGH-RISK FOR PSYCHOSIS

Devrim-Ucok M., Keskin-Ergen H. Y., Yuksel C., Sahin S., Ucok A.
2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 10 - 14 April 2010, vol.117, pp.245 identifier

CHILDHOOD TRAUMA MAY BE RELATED TO TRANSITION TO PSYCHOSIS IN ULTRA HIGH RISK INDIVIDUALS

Sahin S., ÜÇOK V. A., Code E., Yuksel C.
2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 10 - 14 April 2010, vol.117, pp.204 identifier

P300 AMPLITUDE REDUCTION IN SUBJECTS AT ULTRA HIGH-RISK FOR PSYCHOSIS

Keskin-Ergen H. Y., Ucok A., Gode E., Devrim-Ucok M.
2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 10 - 14 April 2010, vol.117, pp.361-362 identifier

A prospective randomized controlled trial of paliperidone ER versus oral olanzapine in patients with schizophrenia

Schreiner A., Korcsog P., Niehaus D. J., Aadamsoo K., Ucok A., Franco M., et al.
27th Collegium Internationale Neuro-Psychopharmacologicum Congress, Hong Kong, PEOPLES R CHINA, 6 - 10 June 2010, vol.13, pp.239 identifier

P3B AMPLITUDE REDUCTION IS NOT PROGRESSIVE OVER THE COURSE OF SCHIZOPHRENIA AFTER THE ONSET OF ILLNESS

Ucok A., Ergen Y. K., Ucok M. D.
12th International Congress on Schizophrenia Research, California, United States Of America, 28 March - 01 April 2009, vol.35, pp.44 identifier

Single-voxel quantitative proton MR spectroscopy in corpus callosum of patients with schizophrenia: Suggests callosal disconnection

Ucok A., Aydin K., Cakir S., Ciftci K.
10th International Congress on Schizophrenia Research, Savannakhet, Laos, 2 - 06 April 2005, vol.33, pp.358 identifier

Association of cognitive functions and interpersonal problem solving capacity with serotonin (102T/C) receptor polymorphism in schizophrenia

Ucok A., Alpsan H., Cakir S., Ozdemir F., Direskeneli G.
13th Biennial Winter Workshop on Schizophrenia Research, Davos, Switzerland, 4 - 10 February 2006, vol.81, pp.197 identifier

Nogo P3 reduction reflects impairment in response inhibition processes in recent-onset schizophrenia

Ertekin E., Keskin-Ergen H., Ucok M., Ucok A.
13th Biennial Winter Workshop on Schizophrenia Research, Davos, Switzerland, 4 - 10 February 2006, vol.81, pp.110-111 identifier

Evaluation of sexual functions of schizophrenic patients under antipsychotics: Multicentered, uninterventional, cross-sectional, epidemiologic study

Aker T., ÜÇOK V. A., Incesu C., Erkoc S.
18th ECNP Congress 2005, Amsterdam, Netherlands, 22 - 26 October 2005, vol.15 identifier

Cognitive predictors of skill acquisition on interpersonal problem solving in patients with schizophrenia

Ucok A., Cetinkaya Z., Cakir S., Discigil A., Kandemir P., Atli H.
12th Biennial Winter Workshop on Schizophrenia, DAVOS, Switzerland, 7 - 13 February 2004, vol.67, pp.261 identifier

P3B and novelty P3A in first-episode and chronic schizophrenia

Ucok M., Ucok A., Keskin Y., Cakir S., Discigil A., Polat A.
12th Biennial Winter Workshop on Schizophrenia, DAVOS, Switzerland, 7 - 13 February 2004, vol.67, pp.134 identifier

The distribution of suicidal behavior and risk factors in patients diagnosed with schizophrenia in a one-year multicenter follow-up study

GÖĞÜŞ A. K., ALPTEKİN K., Erkoc S., Kultur S., Mete L., ÜÇOK V. A., et al.
9th International Congress on Schizophrenia Research, COLORADO SPINGS, COLORADO, 29 March - 02 April 2003, vol.60, pp.16 identifier

Books & Book Chapters

İlk episod şizofreni ; yaklaşım ve tedavi ilkeleri

ÜÇOK V. A.
in: Temel ve Klinik Psikiyatri, K Oğuz Karamustafalıoğlu, Editor, Güneş Tıp Kitapevi Yayınları, Ankara, pp.229-234, 2018

Şizofreni

ÜÇOK V. A., ALNAK A.
in: Maudsley Psikiyatride Reçeteleme Rehberi, Üçok A, Editor, Ema Tıp Kitabevi, İstanbul, pp.44-201, 2017

Mikroplar ve psikiyatrik bozukluklar

ÜÇOK V. A.
in: Enfeksiyon patogenezi ve bağışıklık, Badur S., Abacıoğlu H., Öngen B., Editor, Akademi Yayınevi, İstanbul, pp.1341-1345, 2015

Psikanalitik Kurama Giriş

AKVARDAR Y., TÜKEL M. R., ÜÇOK V. A., YÜCEL B.
Bağlam, 2000